Antimicrobial resistance predicts death in Tanzanian children with bloodstream infections: a prospective cohort study

Table 8 Antimicrobial susceptibility (percentage) of Gram-positive bacteria causing bloodstream infection

Drug	S. aureus		E. faecium*		E. faecalis*
	CA 13	HA 17	CA 12	HA 9	CA 9	HA 6
Penicillin	0	0	10	0	17	75
Ampicillin*	-	-	25	11	100	100
Amoxicillin-clavulanate	77	50	70	11†	100	100
Cloxacillin	92	88	-	-	-	-
Cefuroxime	92	88	-	-	-	-
Ceftazidime	85	80	-	-	-	-
Meropenem	100	100	-	-	-	-
Gentamicin*	100	81	67	33	56	67
Vancomycin*	100	100	100	100	100	100
Erythromycin	100	71	0	0	22	33
Doxycycline	62	35	9	0	25	0
Co-trimoxazole	69	63	27	0	67	40
Chloramphenicol	85	73	50	11	38	33
Ciprofloxacin*	77	81	42	22	100	100
Linezolid*	-	-	100	100	100	100
Quinupristin-dalfopristin*	-	-	100	100	0	17

CA, community-acquired infection; HA, hospital-acquired infection; "-", not done. *E-test was used for susceptibility testing of enterococci against ampicillin, ciprofloxacillin, linezolid, quinupristin-dalfopristin, vancomycin and high-level gentamicin resistance. † Statistically significant difference in susceptibility among hospital-acquired and community-acquired isolates, p < 0.05 by two-sided Fisher's exact test.